Fig. 3From: The expression of miRNA-216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancerExpression of miRNA-216b in different types of NSCLC. A Expression of miRNA-216b in the plasma of patients with early adenocarcinoma. B Expression of miRNA-216b in the plasma of patients with advanced adenocarcinoma. C Expression of miRNA-216b in the plasma of patients with early squamous cell carcinoma. D The expression of miRNA-216b in the plasma of patients with advanced squamous cell carcinoma. E Expression of miRNA-216b in early adenocarcinoma tissue. F Expression of miRNA-216b in advanced adenocarcinoma tissue. G Expression of miRNA-216b in early squamous cell carcinoma tissue. H The expression of miRNA-216b in advanced squamous cell carcinoma. ***P < 0.001 vs. controlBack to article page